DERM
$3.13
Journey Medical
($.02)
(.63%)
DERM
Earnings Whisper ®
N/A
2nd Quarter June 2022
Consensus:  ($0.22)
Revenue:  $24.42 Mil
Tuesday
Aug 9
After the close
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when DERM reports earnings?
Beat
Meet
Miss

Where is DERM's stock price going from here?
Up
Flat
Down
Stock chart of DERM
Analysts
Summary of analysts' recommendations for DERM
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Peers
Vertex PharmaceuticalsMerck & Co.Bristol-Myers SquibbRegeneron PharmaceuticalsUltragenyx PharmaceuticalBioMarin PharmaceuticalJohnson & JohnsonEli LillyPfizerCatalent